Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Medicines Co (MDCO)    
$22.65 0.00 (0.00%) as of 4:30 Mon 10/20


Download
   
Exchange: Nasdaq National Market
Security Type: Common
Shares Out: 65,000,000 as of 12/25
Market Cap: 1.47(B)
Last Volume: 592,961 Avg Vol: 642,793
52 Week Range: $21.17 - $40.39
Level I Sector: Health Care
Level II Sector:   Drugs
Level III Sector:      Drug Manufacturers - Other

Member Indexes:

    NASDAQ BIOTECHNOLOGY       NASDAQ COMPOSITE  
    NASDAQ NNM COMPOSITE  

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  672
Guru Rank Value     : 3
Guru Occurances    : 1

 

            6 Months   1 Year   2 Year  
 
 

Company Profile   Medicines is a biopharmaceutical company. Co. has four marketed products, Angiomax® (bivalirudin), Recothrom® Thrombin, topical (Recombinant), Cleviprex® (clevidipine butyrate) injectable emulsion and its ready-to-use formulation of Argatroban. Co. also has a pipeline of acute and intensive care hospital products in development, including cangrelor, oritavancin, MDCO-157 and IONSYS™ (fentanyl iontophoretic transdermal system), MDCO-216 and ALN-PCS02 and ALN-PCSsc of its ALN-PCS program. Co. also has a portfolio of 10 generic drugs, which it has the non-exclusive right to market in the U.S. Co. also co-promotes the oral tablet antiplatelet medicine BRILINTA® (ticagrelor) in the U.S.

 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 458,468 1,270,266
Total Sell Value $0 $0 $17,312,983 $42,994,560
Total People Sold 0 0 6 8
Total Sell Transactions 0 0 21 72
End Date 2014-07-31 2014-04-29 2013-10-29 2012-10-29

   
Records found: 480
  Page 1 of 20  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Meanwell Clive Chairman & CEO   •       •      –    2014-08-29 4 A $21.77 $9,035 D/D 415 318,719     -
   Sblendorio Glenn President & CFO   •       •      –    2014-08-29 4 A $21.77 $6,422 D/D 295 135,319     -
   Furse Brent EVP, Chief Customer Officer   •       –      –    2014-08-29 4 A $21.77 $9,035 D/D 415 41,044     -
   Kessler Armin M Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 122,874     -
   Spigelman Melvin K Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 34,439     -
   Savage Robert G Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 30,689     -
   Wyatt Elizabeth H S Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 34,439     -
   Shigeta Hiroaki Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 26,939     -
   Hugin Robert J Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 66,939     -
   Crouse William Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 34,439     -
   Kelly John C. Director   –       •      –    2014-05-29 4 A $0.00 $0 D/D 4,590 13,525     -
   Oconnor William Bernard Sr VP & Chief Acct. Officer   •       –      –    2014-03-03 4 D $30.10 $43,402 D/D (1,442) 27,870     -
   Antinori Paul Michael Sr. VP & General Counsel   •       –      –    2014-03-03 4 D $29.99 $33,025 D/D (1,098) 31,080     -
   Oconnor William Bernard Sr VP & Chief Acct. Officer   •       –      –    2014-03-03 4 AS $30.31 $89,960 D/D (2,968) 29,312 -22%     
   Meanwell Clive Chairman & CEO   •       •      –    2014-03-03 4 D $30.10 $260,141 D/D (8,643) 318,304     -
   Kusiak Victoria EVP, Chief Integrity OfficerOf   •       –      –    2014-03-03 3 IO $0.00 $0 D/D 0 3,519 -22%     
   Furse Brent EVP, Chief Customer OfficerOff   •       –      –    2014-03-03 3 IO $0.00 $0 D/D 0 40,629 -22%     
   Sblendorio Glenn President & CFO   •       •      –    2014-03-03 4 D $30.10 $106,820 D/D (3,549) 135,024     -
   Heiman Cornelis EVP, Chief Innovation Officer   •       –      –    2014-03-03 4 A $0.00 $0 D/D 20,000 31,457     -
   Heiman Cornelis EVP, Chief Innovation OfficerO   •       –      –    2014-03-03 3 IO $0.00 $0 D/D 0 11,457 -22%     
   Antinori Paul Michael Sr. VP & General Counsel   •       –      –    2014-03-01 4 A $0.00 $0 D/D 3,682 32,178     -
   Meanwell Clive Chairman & CEO   •       •      –    2014-03-01 4 A $0.00 $0 D/D 60,082 326,947     -
   Sblendorio Glenn President & CFO   •       •      –    2014-03-01 4 A $0.00 $0 D/D 26,383 138,573     -
   Oconnor William Bernard Sr VP & Chief Acct. Officer   •       –      –    2014-03-01 4 A $0.00 $0 D/D 10,504 32,280     -
   Sblendorio Glenn President & CFO   •       •      –    2014-02-28 4 A $25.97 $10,180 D/D 392 112,190     -

  480 Records found
  1  2  3  4  5  6  7  8  9  Next   
  Page 1 of 20
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed